Fresenius Medical Care Fresenius Kabi Fresenius Helios Fresenius Vamed
in new markets - Fresenius Medical Care
for further growth - Fresenius Kabi
for better health - Fresenius Helios
for greater efficiency - Fresenius Vamed
close

Seizing opportunities > in new markets

Asia is an important growth market for Fresenius Medical Care. Approximately 620,000 patients with chronic kidney failure are currently being treated in this region, and every year this number increases by about 10 to 11%. We will continue to take advantage of this growth potential. The significant demand for dialysis services offers substantial opportunities to expand our network of clinics in the Asian countries.

In 2008, Fresenius Medical Care achieved sales of US$ 606 million in the Asia-Pacific region. Our goal is to continue our strong organic growth and to increase sales to more than US$ 800 million in constant currency by 2010.

FRESENIUS MEDICAL CARE IN ASIA
  2008 2007 Change
Sales (in million US$) 606 541 12%
Employees (December 31) 3,558 3,095 15%
Dialysis patients (December 31) 9,158 7,789 18%
Dialysis treatments (million) 1.34 1.21 11%
Dialysis clinics (December 31) 125 105 19%
 

READ MORE ABOUT FRESENIUS MEDICAL CARE >>

close
in new markets - Fresenius Medical Care
close

Seizing opportunities > for further growth

With the acquisition of APP Pharmaceuticals, Fresenius Kabi has achieved a leading position in the global market for intravenously administered generic drugs. APP Pharmaceuticals has a strong drug registration portfolio pending and over 70 products under development, opening up new growth opportunities.

At the same time, we are seizing the opportunity of introducing selected Kabi products into the US, with initial focus on parenteral nutrition. We are also planning to launch selected APP IV drugs outside the US.

APP PHARMACEUTICALS IN FIGURES
  2008
Sales US$ 777 million
EBITDA, adjusted* US$ 317 million
EBITDA margin, adjusted* 40.8%
Employees (December 31, full-time equivalent) 1,487
Production facilities 3
Produkte >100
Number of products ~17%
 

READ MORE ABOUT FRESENIUS KABI >>

close
for further growth - Fresenius Kabi
close

Seizing opportunities > for better health

At Fresenius Helios, our commitment is to provide the highest medical quality and care. We aim to offer advanced and proven best-in-class diagnosis and treatment methods for the benefit of our patients. We continuously invest in high-quality, state-of-the-art medicine, and aim to measure and improve the quality of medical care.

Our target ist that our quality indicators should be better than the German average. With a mortality rate of SMR < 1, this was accomplished, among others, for major illnesses shown below.

HELIOS QUALITY INDICATORS
Indications/
standardized mortality rate (SMR)*
2008
SMR
2007
SMR
Acute myocardial infarction 0.73 0.79
Heart failure 0.73 0.85
Stroke 0.83 1.01
Acute cerebral infarction 0.81 0.99
Pneumonia 0.71 0.85
 

READ MORE ABOUT FRESENIUS HELIOS >> 

close
for better health - Fresenius Helios
close

Seizing opportunities > for greater efficiency

Fresenius Vamed is a leading international provider of services in the planning, construction, and management of health care facilities. Our complete value chain and our more than 25 years of international experience are key to providing effective support for hospitals at every stage of their life cycle, and thus contributing towards their successful operating performance. For us, each project is another opportunity to prove our competence.

Hospitals face the dual challenge of increasing efficiency and reducing expenditure. We support hospitals by offering comprehensive process know-how and by taking over medical-technical services and management functions.

VAMED SERVICES
   
Service contracts* for   140 clinics
  ~ 50,000 beds
among others:  
Vienna General Hospital and University Clinics (AKH) ~ 2,100 beds
Charité Hospital Berlin ~ 3,200 beds
University Clinic Hamburg-Eppendorf ~1,370 beds
Prince Court Medical Center, Kuala Lumpur ~ 330 beds
Al Ain Hospital, Abu Dhabi ~ 450 beds
 

READ MORE ABOUT FRESENIUS VAMED >>

close
for greater efficiency - Fresenius Vamed
  • Print page
  • Save as PDF
  • Add to Cart
  • Recommend Page

Print

By defining both our corporate goals and our internal processes for the long term, we can make sure that our activities meet the needs of patients, employees, and third parties on a sustainable basis.

Our products provide optimum care for the severely and chronically ill. To the patients’ benefit, we are constantly striving to develop new therapies and to improve the performance of existing products.

Our employees are the foundation of our company’s success. We are committed to further the development of our employees through a wide range of measures and actively promote international and divisional cooperation.

Our processes conform to the highest quality and safety standards as well as the needs of environmental protection and thus the conservation of natural resources.

EMPLOYEES

The high qualification standards and commitment of our employees are the basis of our growth, evidenced by the wideranging opportunities offered to employees for assuming responsibility early in their careers. The Fresenius Group is a favored employer, not only for national and international university graduates, school leavers, and qualified specialists but also for internships and degree projects.

The successes achieved in our personnel activities have encouraged us to address other challenging projects. In addition to employee development and personnel marketing, we are also focusing on the management of demographic change. A distinctive impact of the demographic development is that fewer young employees will be available. So, an important strategic task is to prepare our staff for a longer working life and to offer even more attractive career opportunities for young employees.

EMPLOYEE DEVELOPMENT AND PERSONNEL MARKETING

Employee development at Fresenius aims to prepare employees for the dynamic business developments that lie ahead, and to support them in responding to changes and opportunities early on by accepting these as a positive challenge. Since needs in the various business segments differ, all employee development concepts are formulated and implemented according to specific requirements.

In the development of international top management executives, we again collaborated successfully in the past year with our longstanding partner, the INSEAD Business School, with locations in Fontainebleau, Singapore, and Abu Dhabi. A special focus was on the international networking of the course participants. The resulting personal, strategic, and procedural challenges are part of the current program.

Another target is providing the various business segments and their employees with professional support when faced with growth-induced organizational changes. Organizational development measures can, for instance, build on segmentspecific employee surveys and analyze and form the basis for tailored concepts.

Fresenius also continuously supports its employees through a comprehensive range of training measures to enhance their professional, personal, and leadership skills, designed to develop and tap their individual strengths. The targeted, organized transfer of an employee’s know-how to a successor makes sure that the knowledge does not get lost.